On September 2, 2020 Harpoon Therapeutics, Inc. (NASDAQ: HARP), a clinical-stage immunotherapy company developing a novel class of T cell engagers, reported that Gerald McMahon, Ph.D., President and Chief Executive Officer, will participate in two upcoming virtual investor conferences (Press release, Harpoon Therapeutics, SEP 2, 2020, View Source [SID1234564324]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A fireside chat at Baird’s 2020 Global Healthcare Conference on Wednesday, September 9, 2020 at 3:45 p.m. ET / 12:45 p.m. PT; and

A "Novel Antibodies and Protein Therapeutics in Oncology" panel at Citi’s 15th Annual BioPharma Virtual Conference on Thursday, September 10, 2020 at 10:45 a.m. ET / 7:45 a.m. PT.
A live audio webcast of the fireside chat at the Baird conference will be available in the Investors section of Harpoon Therapeutics’ website at www.harpoontx.com with an archived replay available following the event.